Territory Commercial Manager - Multi-Product Lines
About the job
- Strong commercial negotiation and project management skills.
- A solid scientific culture and knowledge of the medical biology market are major advantages for the role.
- Strong interpersonal relationship-building, analytical, synthesis, and data management skills.
- Business acumen and the ability to analyze and understand the strategic and commercial issues of the in vitro diagnostics and broader healthcare industries.
- Consulting skills, including attentive listening, translating requests into needs, aligning stakeholders around a shared vision, providing expert advice, and effective contracting.
- Inspirational leadership capable of engaging and influencing while collaborating cross-functionally.
- Fluent English communication skills for working in an international environment.
- Serve as the preferred point of contact for customer organizations by understanding their structures and decision-making processes, developing trusted relationships, identifying needs, coordinating actions, and maintaining customer information in the customer relationship management system.
- Acquire, retain, and develop customer accounts by creating and updating account plans, managing sales opportunities, negotiating contracts, preparing commercial offers, ensuring commitments are met, and resolving disputes.
- Maintain and develop professional expertise by actively completing training, integrating information, and using provided tools to inform customers.
- Ensure cross-functional collaboration, synergy, and communication within the company by developing exchanges between departments, ensuring contract completeness, respecting colleagues' areas of expertise, and contributing expertise to customer satisfaction.
- Knowledge of the medical biology market.
About the company
Roche is a global leader in pharmaceuticals and diagnostics. It develops medicines and diagnostic tools that help detect, monitor, and treat diseases, using research and biotechnology to drive new therapies and tests. Roche combines drug development with in-house diagnostic products to support personalized medicine, where treatments are tailored to individual patients based on test results. Its approach differs from many peers by integrating drug discovery with diagnostic capabilities and by expanding its research through strategic acquisitions (like Genentech) to strengthen its biotechnology and R&D capabilities. The company’s goal is to improve patient outcomes and healthcare worldwide by delivering reliable medicines, accurate diagnostic tests, and data-driven care.
Company Size
1-10
Company Stage
IPO
Headquarters
Basel, Switzerland
Founded
1896
Get referred to Roche
See people who can refer or advise you
Simplify's Take
What believers are saying
- Enicepatide delivered 15.5% weight loss in September 2026 and 22.7% in June.
- pTau217 can scale immediately through Roche's existing lab network and improve Alzheimer diagnostics.
- Roche's June 2026 data and September 2026 filings signal multiple obesity shots on goal.
What critics are saying
- Eli Lilly and Novo Nordisk dominate obesity pricing, distribution, and physician mindshare today.
- Enicepatide remains Phase II-only; Roche starts late-stage glycemic and cardiovascular studies in 2027.
- If enicepatide disappoints, Roche burns its $2.7 billion Carmot bet and loses obesity credibility.
What makes Roche unique
- Roche combines pharma, diagnostics, and installed cobas labs across 4,500 U.S. instruments.
- Elecsys pTau217 won FDA clearance on August 24, 2026, and CE marking September 7.
- Roche controls obesity assets from Carmot and Zealand, spanning GLP-1/GIP and amylin.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Performance Bonus